Visual showing a schematic stem cell

Pluripotent Stem Cells –
From Research to Therapy

Do you need to take your pluripotent stem cell research to the clinic?

 

Pluripotent stem cells (PSCs) have the ability to generate the 220+ cell types in the human body. Because of this unique attribute, these cells have great potential in basic research, drug discovery and cell replacement therapies.

 

In 2011, Lonza began development of a clinical grade master cell bank, uncovering a need for tools to support working with PSCs in both research and clinical settings. The ability to streamline your PSC workflow through any stage of research and development can save you time, effort and money.

 

Please view the recorded webinar and learn how to maximize your stem cell research efforts.

 

With Lonza's L7™ hiPSC Reprogramming and hPSC Culture System and Nucleofector™Technology for transfecting non-integrating episomal reprogramming factors, you have solutions for your human PSC workflow at your fingertips.

 

View Archived Webinar    Topics 
View complimentary webinar

 

  • Technical challenges of iPSC-based therapies
  • General considerations for iPSC researchers with clinical aspirations
  • Our new L7™ hiPSC Reprogramming Bundle for the generation of PBMC-derived iPSCs
  • L7™ hPSC Culture System for xeno-free, defined culturing of hPSCsApplication examples
Duration: 51 minutes  
Date: 16 June 2015  

Speaker: Andrew Winner
Scientific Support Specialist
Lonza Walkersville, Inc.

   

 

For further information, please visit www.lonza.com/l7.

View our webinar schedule to not miss any of our upcoming tutorials. Find further previously recorded webinars in our webinar archive.